NCT00933439View on ClinicalTrials.gov

Assessment of Cognitive Functioning Before and After Treatment With Duloxetine

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Duloxetine

Approximately 30 participants with major depressive disorder and concentration and/or cognition difficulties, recruited from the community and physician referrals, will be treated with duloxetine for 12 weeks. Their cognitive performance will be assessed pre- and post-treatment with a cognitive testing battery.

Trial Locations (1)

75390

Mood Disorders Research Program and Clinic - UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00933439 - Assessment of Cognitive Functioning Before and After Treatment With Duloxetine | Biotech Hunter | Biotech Hunter